Profile data is unavailable for this security.
About the company
Medartis Holding AG is a Switzerland-based holding company of the Medartis Group, which is engaged in manufacturing medical devices and implants. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. It has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.
- Revenue in CHF (TTM)212.01m
- Net income in CHF619.00k
- Incorporated1997
- Employees829.00
- LocationMedartis Holding AGHochbergerstrasse 60EBASEL 4057SwitzerlandCHE
- Phone+41 616333434
- Fax+41 616333400
- Websitehttps://www.medartis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CellaVision AB | 60.69m | 12.10m | 535.48m | 223.00 | 44.25 | 8.24 | 34.35 | 8.82 | 5.92 | 5.92 | 29.69 | 31.81 | 0.757 | 1.68 | 8.45 | 3,106,469.00 | 15.09 | 15.30 | 17.34 | 18.24 | 67.52 | 69.03 | 19.94 | 19.98 | 2.21 | 66.29 | 0.0688 | 110.18 | 5.94 | 13.17 | 10.12 | 8.00 | 30.45 | 8.45 |
| Advanced Medical Solutions Group plc | 145.08m | 18.26m | 542.31m | 850.00 | 29.96 | 1.93 | 17.69 | 3.74 | 0.0724 | 0.0724 | 0.5755 | 1.12 | 0.4426 | 1.75 | 5.34 | 148,482.40 | 5.57 | 6.54 | 6.04 | 7.06 | 55.57 | 56.75 | 12.59 | 14.82 | 4.00 | -- | 0.0361 | 25.85 | 1.51 | 4.23 | -22.14 | -6.71 | 15.66 | 12.32 |
| Stratec SE | 246.79m | 11.88m | 566.66m | 1.47k | 47.69 | 2.53 | 19.17 | 2.30 | 0.9991 | 0.9991 | 20.75 | 18.86 | 0.5906 | 1.34 | 5.11 | 165,771.40 | 2.84 | 7.07 | 3.55 | 8.20 | 25.60 | 27.32 | 4.81 | 9.70 | 0.8029 | 4.41 | 0.3826 | 40.81 | -4.63 | 6.88 | -55.29 | 3.30 | -2.16 | -7.68 |
| medmix AG | 486.60m | 300.00k | 694.03m | 2.66k | 1,678.64 | 1.47 | 12.39 | 1.43 | 0.01 | 0.01 | 11.91 | 11.41 | 0.4606 | 3.65 | 6.05 | 183,070.00 | 0.0663 | 2.06 | 0.0846 | 2.49 | 32.41 | 36.38 | 0.1439 | 4.16 | 1.23 | 2.92 | 0.4244 | 67.70 | 1.99 | 1.40 | -97.41 | -64.36 | 12.01 | -- |
| Paul Hartmann AG | 2.30bn | 27.80m | 701.78m | 10.17k | 25.12 | 0.6713 | 5.28 | 0.3049 | 8.00 | 8.00 | 662.57 | 299.40 | 1.18 | 2.02 | 5.72 | 231,438.00 | 1.64 | 3.87 | 2.26 | 5.34 | 56.01 | 56.71 | 1.39 | 2.98 | 1.16 | 4.87 | 0.1865 | 42.75 | 1.80 | 2.12 | -21.37 | -18.49 | 5.95 | 2.71 |
| Revenio Group Oyj | 94.56m | 18.59m | 733.88m | 216.00 | 39.03 | 7.49 | 32.69 | 7.76 | 0.7205 | 0.7205 | 3.66 | 3.76 | 0.7069 | 5.50 | 7.60 | 447,574.10 | 13.90 | 14.33 | 16.77 | 17.90 | 51.01 | 50.73 | 19.66 | 21.13 | 1.79 | 28.49 | 0.1521 | 55.81 | -0.4125 | 25.80 | -12.15 | 18.72 | 17.67 | 6.30 |
| Synsam AB (publ) | 515.42m | 29.82m | 755.78m | 3.52k | 25.15 | 3.37 | 8.06 | 1.47 | 2.34 | 2.34 | 40.45 | 17.46 | 0.7272 | 2.05 | 10.94 | 1,762,379.00 | 4.18 | -- | 5.85 | -- | 75.31 | -- | 5.75 | -- | 0.50 | -- | 0.5659 | -- | 11.90 | -- | -5.18 | -- | -- | -- |
| El En SpA | 677.16m | 47.19m | 787.89m | 2.11k | 16.66 | 2.32 | 13.01 | 1.16 | 0.6038 | 0.6038 | 8.67 | 4.33 | 0.9515 | 2.04 | 4.05 | 332,511.90 | 6.88 | 7.43 | 12.83 | 13.52 | 39.14 | 38.83 | 7.23 | 7.63 | 1.20 | 232.14 | 0.164 | -- | 2.78 | 14.88 | -12.47 | 23.49 | -13.40 | -- |
| Draegerwerk AG & Co KGaA | 3.28bn | 98.28m | 887.23m | 16.48k | 8.72 | 0.6117 | 3.61 | 0.2709 | 5.36 | 5.36 | 178.48 | 76.35 | 1.11 | 2.61 | 4.94 | 205,046.00 | 3.39 | 3.26 | 5.03 | 4.87 | 43.32 | 44.16 | 3.06 | 3.05 | 1.17 | 5.79 | 0.1662 | 11.38 | 10.78 | 5.39 | 271.05 | 33.87 | 2.64 | 55.73 |
| Arjo AB (publ) | 951.24m | 44.39m | 1.01bn | 6.71k | 24.36 | 1.56 | 7.60 | 1.06 | 1.90 | 1.90 | 40.76 | 29.72 | 0.6911 | 4.15 | 6.31 | 1,632,980.00 | 3.21 | 3.55 | 4.44 | 5.55 | 43.43 | 44.01 | 4.64 | 5.41 | 0.6913 | 4.14 | 0.4024 | 43.01 | 10.03 | 5.97 | 6.90 | 10.15 | -8.89 | 10.35 |
| Medartis Holding AG | 212.01m | 619.00k | 1.04bn | 829.00 | 1,567.62 | 3.71 | 48.05 | 4.90 | 0.0488 | 0.0488 | 17.33 | 20.63 | 0.6259 | 0.643 | 5.27 | 255,737.00 | 0.183 | 0.1919 | 0.2095 | 0.2153 | 79.04 | 82.33 | 0.2924 | 0.3542 | 1.59 | 1.46 | 0.1655 | 0.00 | 15.96 | 11.81 | 110.70 | -31.82 | 5.37 | -- |
| Oxford Nanopore Technologies PLC | 195.03m | -177.60m | 1.06bn | 1.24k | -- | 1.43 | -- | 5.46 | -0.1851 | -0.1851 | 0.2035 | 0.7493 | 0.212 | 0.8369 | 2.73 | 137,050.10 | -19.30 | -21.12 | -21.93 | -24.67 | 53.33 | 53.90 | -91.06 | -81.85 | 3.87 | -- | 0.0608 | -- | -14.57 | 39.15 | -69.74 | -- | 8.92 | -- |
| GVS SpA | 415.39m | 20.09m | 1.13bn | 4.39k | 58.40 | 3.34 | 17.74 | 2.73 | 0.1135 | 0.1135 | 2.38 | 1.99 | 0.4201 | 1.95 | 6.20 | 96,823.30 | 2.03 | 7.35 | 2.50 | 10.82 | 53.92 | 58.74 | 4.84 | 12.44 | 1.19 | 3.87 | 0.5709 | -- | 9.58 | 15.25 | -43.37 | -9.97 | 16.08 | -- |
| Xvivo Perfusion AB | 55.09m | 8.61m | 1.19bn | 148.00 | 132.65 | 6.92 | 84.07 | 21.56 | 3.32 | 3.32 | 21.18 | 63.59 | 0.322 | 1.28 | 4.27 | 4,018,431.00 | 5.03 | 1.24 | 5.49 | 1.33 | 73.94 | 73.14 | 15.62 | 4.76 | 3.40 | -- | 0.0152 | 0.00 | 43.88 | 26.04 | 398.29 | 48.57 | 21.35 | -- |
| Biotage AB | 169.75m | 20.22m | 1.27bn | 669.00 | 61.58 | 3.81 | 36.81 | 7.49 | 3.01 | 3.01 | 25.57 | 48.61 | 0.5276 | 2.01 | 7.78 | 2,939,169.00 | 6.29 | 10.74 | 7.33 | 12.77 | 62.19 | 61.34 | 11.91 | 15.77 | 1.52 | 8.95 | 0.062 | 40.11 | 18.90 | 15.37 | -8.21 | 7.97 | 14.05 | 1.30 |
Data as of May 31 2024. Currency figures normalised to Medartis Holding AG's reporting currency: Swiss Franc CHF
16.59%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nordflint Capital Partners Fondsm�glerselskab A/Sas of 21 Mar 2023 | 1.39m | 10.27% |
| Pictet Asset Management SAas of 31 Jan 2024 | 248.69k | 1.83% |
| The Vanguard Group, Inc.as of 09 May 2024 | 149.59k | 1.10% |
| BlackRock Investment Management (UK) Ltd.as of 30 Apr 2024 | 85.92k | 0.63% |
| Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024 | 77.49k | 0.57% |
| Deka Investment GmbHas of 31 Dec 2023 | 72.75k | 0.54% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 72.01k | 0.53% |
| UBS Asset Management Switzerland AGas of 07 May 2024 | 57.40k | 0.42% |
| Z�rcher Kantonalbank (Investment Management)as of 28 Mar 2024 | 54.12k | 0.40% |
| Vontobel Asset Management AGas of 30 Apr 2024 | 38.73k | 0.29% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
